期刊文献+

大肠癌中聚(腺苷二磷酸核糖)水解酶对聚(腺苷二磷酸核糖)聚合酶的调节作用及意义 被引量:3

Regulatory effects of PARG on PARP in colorectal carcinoma
下载PDF
导出
摘要 目的初步探讨大肠癌中聚(腺苷二磷酸核糖)水解酶[Poly(ADP-ribose)glycohydrolase,PARG]与聚(腺苷二磷酸核糖)聚合酶[Poly(ADP-ribose)polymerase,PARP]的关系。方法应用S-P免疫组化检测人大肠癌组织中PARG、PARP的表达;以PARG抑制剂丹宁酸(Gallotannin,GLTN)为处理因素,采用流式细胞计数检测小鼠结肠腺癌CT26细胞中PARG、PARP表达变化。结果PARG和PARP在人大肠癌组织中的表达呈正相关(r=0.300 01,P<0.05);流式细胞计数显示,用GLTN处理后,小鼠结肠腺癌CT26细胞中PARG、PARP的阳性细胞率分别较对照组降低,差异具有统计学意义(P<0.05)。结论大肠癌中PARG和PARP的表达有相关性,PARG抑制剂可以抑制PARG及PARP表达,PARG可能对PARP具有调节作用。 Objective To study the relationship between Poly (ADP-ribose) glycohydrolase (PARG) and Poly(ADP-ribose) polymerase (PARP) in colorectal carcinoma. Methods Immunohistochemical S-P staining was used to examine the expressions of PARG and PARP in 44 specimens human colorectal carcinoma. The positive rate of PARG and PARP in routine colon carcinoma CT26 cells was detected by flow cytometry before and after the treatment of PARG inhibitor Gallotannin. Results PARG and PARP expressed in colorectal carcinoma specimens was of positive correlation (r = 0. 300 01, P 〈 0.05 ). The expressions of PARG and PARP were weaker in Gallotannin-treated CT26 cells than those in the control cells (P 〈 0.05). Conclusion The expressions of PARG and PARP are correlated positively in colorectal carcinoma. PARC inhibitor suppresses the expressions of both PARG and PARP, indicating that PARG may regulate PARP.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2009年第5期420-422,共3页 Journal of Third Military Medical University
基金 重庆市自然科学基金(2006BB52881)~~
关键词 聚(腺苷二磷酸核糖)水解酶 聚(腺苷二磷酸核糖)聚合酶 大肠癌 Poly(ADP-ribose) glycohydrolase Poly(ADP-ribose) polymerase colorectal carcinoma
  • 相关文献

参考文献10

  • 1Woon E C, Threadgill M D. Poly(ADP-ribose) polymerase inhibition - where now? [J]. Curr Med Cbem, 2005,12(20) : 2373 -2392.
  • 2Tentori L, Leonetti C, Scarsella M, et al. Inhibition of poly( ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma [J]. FASEBJ, 2006, 20(10):1709-1711.
  • 3Rajesh M, Mukhopadhyay P, Godlewski G, et al. Poly(ADP-ribose) polymerase inhibition decreases angiogenesis [ J ]. Biochem Biophys Res Commun,2006,350(4) : 1056-1062.
  • 4郝兰香,王娅兰,李圆圆.大肠癌PARP表达与P-selectin和ICAM-1表达的相关性[J].基础医学与临床,2006,26(8):882-887. 被引量:17
  • 5Cuzzocrea S, Di-Paola R, Mazzon E, et al. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion [J]. FASEB J, 2005,19(6): 558 - 566.
  • 6Cuzzocrea S, Mazzon E, Genovese T, et al. Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice[ J]. Free Radic Biol Med, 2007,42( 1 ) : 90 - 105.
  • 7Brown R S, Wahl R L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study [ J]. Cancer, 1993, 72(10) : 2979 -2985.
  • 8Lu X C, Massuda E, Lin Q, et al. Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat[ J]. Brain Res, 2003,978( 1 -2) : 99 - 103.
  • 9蔡莉,王娅兰,林晓.PARP抑制与小鼠结肠癌CT26细胞生长活性的关系[J].重庆医科大学学报,2008,33(2):136-139. 被引量:4
  • 10黎明,蔡莉,王娅兰.PARP抑制剂5-AIQ对CT26细胞侵袭及转移的影响[J].第三军医大学学报,2008,30(3):237-240. 被引量:5

二级参考文献40

  • 1贾晓青,钟宁,王菁华,张尚忠.NS-398降低结肠癌细胞系HT-29体外侵袭力[J].基础医学与临床,2004,24(5):547-551. 被引量:5
  • 2李治国,王继见.核转录因子在大肠癌中的研究进展[J].现代医药卫生,2005,21(19):2621-2622. 被引量:2
  • 3高静,王娅兰.大肠癌核基质蛋白变化与其生物学行为的关系[J].重庆医科大学学报,2006,31(3):302-306. 被引量:3
  • 4郝兰香,王娅兰,李圆圆.大肠癌PARP表达与P-selectin和ICAM-1表达的相关性[J].基础医学与临床,2006,26(8):882-887. 被引量:17
  • 5Szabo G,Bahrle S,Stumpf N,et al.Poly (ADP-ribose)polymerase inhibition reduces reperfusion injury after heart transplantation[J].Cir Res,2002,90:100-106.
  • 6Shiobara M,Miyazaki M,Ito H,et al.Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma[J].J Gastroenterol Hepatol,2001,16:338-344.
  • 7梁智勇.大肠和肛门疾病[M]//史景全,陈意生.现代外科病理学.2版.北京:人民军医出版社,1998:159-161.
  • 8Brow RS,Wahl RL.Overexpression of glut-1 glucose transporter in human breast cancer:an immunohistochemical study[J].Cancer,1993,72:2979-2985.
  • 9曾常茜.荧光免疫显微技术[M]//吕世静.免疫学检验.2版.北京:人民卫生出版社,2003:139-142.
  • 10Hirai K,Ueda K,Hayaishi O.Aberration of poly(adenosine diphosphate-ribose) metabolism in human colon adenomatous polyps and cancers[J].Cancer Res,1983,43:3441-3446.

共引文献20

同被引文献28

  • 1郝兰香,王娅兰,蔡莉,李园园.5-AIQ对大肠癌细胞系HT-29细胞PARP活性抑制的生物学作用[J].癌症,2007,26(6):566-571. 被引量:6
  • 2Ou J, Li J, Pan F, et al. Endostatin suppresses eolorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin a9 [J]. J Cell Biochem, 2011,4. doi: 10.1002/ jcb. 23130.
  • 3Woon E C, Threadgill M D. Poly(ADP-ribose) polymerase inhibition where now? [J]. Curr Med Chem, 2005, 12(20) : 2373 -2392.
  • 4Cortes U, Tong W M, Coyle D L, et al. Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice [ J ]. Mol Cell Biol, 2004, 24 (16) : 7163 -7178.
  • 5Lu X C, Massuda E, Lin Q, et al. Post-treatment with a novel PARG inhibitor reduces infarct in cerebral iscbemia in the rat[ J]. Brain Rcs, 2003, 978(1/2): 99-103.
  • 6Koh D W, Lawler A M, Poitras M F, et al. Failure to degrade poly (ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality[J]. Proc Natl Acad Sci U S A, 2004, 101 (51): 17699 - 17704.
  • 7Cuzzocrea S, Mazzon E, Genovese T, et al. Role of poly(ADP-ribose) glycohydrolase in the development of inilammatory bowel disease in mice[ J]. Free Radic Biol Med, 2007, 42( 1 ): 90 -105.
  • 8Skobe M, Hawigborst T, Jackson D G, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis [ J ]. Nat Med, 2001,7(2): 192-198.
  • 9Zhang D, Li B, Shi J, et al. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein[J]. Cancer Res, 2010, 70(6): 2495 -2503.
  • 10Rapizzi E, Fossati S, Moroni F, et al. Inhibition of poly( ADP-Ribose) glycohydrolase by gallotannin selectively up-regulates expression of proinflammatory genes[J]. Mol Pharmaeol, 2004, 66(4) : 890 - 898.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部